US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 4.650
  • -0.020-0.43%
Close May 31 16:00 ET
  • 4.770
  • +0.120+2.58%
Post 16:08 ET
194.62MMarket Cap-3522P/E (TTM)

Zevra Therapeutics Key Stats

Zevra Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

3.43M

+7.84%
EPS(YoY)

-0.40

-5.26%

Strong Buy

May 31, 2024

Zevra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.562M--
--2024/Q2-- / 4.519M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--
Nov 7, 20232023/Q32.895M / 3.379M--
Aug 14, 20232023/Q28.470M / 3.033M--
May 15, 20232023/Q12.879M / 2.655M--
Mar 7, 20232022/Q42.319M / 3.100M--
Nov 9, 20222022/Q32.874M / 3.012M--
Aug 11, 20222022/Q21.300M / 1.748M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.562M--
--2024/Q2-- / 4.519M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--
Nov 7, 20232023/Q32.895M / 3.379M--
Aug 14, 20232023/Q28.470M / 3.033M--
May 15, 20232023/Q12.879M / 2.655M--
Mar 7, 20232022/Q42.319M / 3.100M--
Nov 9, 20222022/Q32.874M / 3.012M--
Aug 11, 20222022/Q21.300M / 1.748M--

Unlock Free Earnings Estimates

Zevra Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg